(1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione

C38H43N7O3 — CID 163312986

IUPAC(1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione
SMILESC[C@H]1NC(=O)CCC[C@H]2[C@@H]3C[C@@H](CN(Cc4cn(-c5ccccc5)nc4-c4ccncc4)C3)CN2C(=O)[C@H](Cc2ccccc2)NC1=O
InChIInChI=1S/C38H43N7O3/c1-26-37(47)41-33(20-27-9-4-2-5-10-27)38(48)44-22-28-19-30(34(44)13-8-14-35(46)40-26)23-43(21-28)24-31-25-45(32-11-6-3-7-12-32)42-36(31)29-15-17-39-18-16-29/h2-7,9-12,15-18,25-26,28,30,33-34H,8,13-14,19-24H2,1H3,(H,40,46)(H,41,47)/t26-,28+,30-,33+,34+/m1/s1
InChIKeySSRLRBQVWHPLPL-JDATUECUSA-N
MW645.81 g/mol
LogP4.00
Rot. Bonds6

About (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione

(1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione (PubChem CID 163312986) has the molecular formula C38H43N7O3 and a molecular weight of 645.81 g/mol. Its IUPAC name is (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione.

Molecular Properties

Compound Name(1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione
PubChem CID163312986
Molecular FormulaC38H43N7O3
Molecular Weight645.81 g/mol
Exact Mass645.34
IUPAC Name(1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione
SMILESC[C@H]1NC(=O)CCC[C@H]2[C@@H]3C[C@@H](CN(Cc4cn(-c5ccccc5)nc4-c4ccncc4)C3)CN2C(=O)[C@H](Cc2ccccc2)NC1=O
InChIInChI=1S/C38H43N7O3/c1-26-37(47)41-33(20-27-9-4-2-5-10-27)38(48)44-22-28-19-30(34(44)13-8-14-35(46)40-26)23-43(21-28)24-31-25-45(32-11-6-3-7-12-32)42-36(31)29-15-17-39-18-16-29/h2-7,9-12,15-18,25-26,28,30,33-34H,8,13-14,19-24H2,1H3,(H,40,46)(H,41,47)/t26-,28+,30-,33+,34+/m1/s1
InChIKeySSRLRBQVWHPLPL-JDATUECUSA-N
XLogP4.00
TPSA112.46 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms48
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500645.81
LogP ≤ 54.00
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione?
The IUPAC name of (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione (CID 163312986) is (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione.
What is the SMILES notation for (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione?
The canonical SMILES for (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione is C[C@H]1NC(=O)CCC[C@H]2[C@@H]3C[C@@H](CN(Cc4cn(-c5ccccc5)nc4-c4ccncc4)C3)CN2C(=O)[C@H](Cc2ccccc2)NC1=O.
What is the InChIKey of (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione?
The InChIKey is SSRLRBQVWHPLPL-JDATUECUSA-N. The full InChI is InChI=1S/C38H43N7O3/c1-26-37(47)41-33(20-27-9-4-2-5-10-27)38(48)44-22-28-19-30(34(44)13-8-14-35(46)40-26)23-43(21-28)24-31-25-45(32-11-6-3-7-12-32)42-36(31)29-15-17-39-18-16-29/h2-7,9-12,15-18,25-26,28,30,33-34H,8,13-14,19-24H2,1H3,(H,40,46)(H,41,47)/t26-,28+,30-,33+,34+/m1/s1.
What are the key properties of (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione?
(1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione has a molecular weight of 645.81 g/mol, XLogP of 4.00, 6 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2S,8R,11S,15S)-11-benzyl-8-methyl-17-[(1-phenyl-3-pyridin-4-ylpyrazol-4-yl)methyl]-7,10,13,17-tetrazatricyclo[13.3.1.02,13]nonadecane-6,9,12-trione is sourced from PubChem (CID 163312986), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).